A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Iron-deficient Blood Donors
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to evaluate the effect of IV iron isomaltoside 1000
compared with placebo on Hb in first-time female donors with p-ferritin below 30 µg/L